Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Anteris Technologies Global Corp. Capital/Financing Update 2010

Mar 29, 2010

33869_rns_2010-03-29_7f1662a6-9461-4a6b-bd60-a9c0c6fca570.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

==> picture [596 x 64] intentionally omitted <==

Innovative BioMedical Devices

Level 11, 225 St Georges Terrace bioMD Limited ABN 35 088 221 078 Perth, Western Australia 6000 PO Box 7209, Cloisters Square Western Australia 6850

Telephone (08) 9262 6777 Facsimile (08) 9322 3433

www.biomd.com.au

ANNOUNCEMENT TO THE AUSTRALIAN STOCK EXCHANGE

1 of 1 page

30 March 2010

Company Announcements Office Australian Securities Exchange Limited 10[th] Floor, 20 Bond Street SYDNEY NSW 2000

Entitlements Offer Extended

bioMD Limited opened its non-renounceable offer for New Options on 17 March 2010 and there has been a positive response to the Offer.

The Directors are aware of both Easter and school holidays occurring and have decided to extend the offer until Friday 9 April .

Eligible shareholders should use the Entitlement and Acceptance form that was mailed to them earlier this month to apply for the New Options. All cheques must be drawn on an Australian bank or bank draft made payable in Australian currency to bioMD Limited – NRE Account and crossed not negotiable.

Please note that the BPay facility will not be available for this extension.

Your completed Entitlement and Acceptance form and cheque must reach the Company’s Share Registry at the address below no later than 5.00pm (WST) on 9 April 2010 :

Computershare Investor Services Pty Ltd Locked Bag 2508 Perth WA 6001

Yours faithfully

Caroline Bentley Company Secretary

==> picture [596 x 41] intentionally omitted <==